Uninamous approval for Dvax Hepititas B vaccine. 1 billion plus in annual sales after approval for diabetes indication too!
Let it be written,
Dr. Tony Montello
Sentiment: Strong Buy
GSK & MRK possible suitors. They currently share the Hep B vaccine mkt. DVAX's superior Heplisav Hep B vaccine would certainly help one of them. Would take care of patent issues too. Two birds with one stone.
GSK is in front of the AdCom right now, maybe they can dicuss things over lunch.
Hey, A Tony O
I like a your thinking*